+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Organs Market by Organ Type, Product Type, Technology, End User, Distribution Channel - Global Forecast to 2030- Product Image
Artificial Organs Market by Organ Type, Product Type, Technology, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Artificial Organs Market by Organ Type, Product Type, Technology, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6013919
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Organs Market grew from USD 24.30 billion in 2024 to USD 26.45 billion in 2025. It is expected to continue growing at a CAGR of 8.45%, reaching USD 39.56 billion by 2030.

Charting the Evolution of Life-Saving Technologies

Pioneering the frontier of artificial organs demands an understanding of the remarkable strides that science and engineering have achieved. This summary offers a concise orientation, framing the market’s evolution from rudimentary mechanical pumps and dialysis machines to sophisticated tissue engineered constructs and bioartificial solutions. At its core, this introduction underscores how unmet clinical needs-driven by rising incidence of organ failure and donor shortages-have catalyzed research investments and cross-disciplinary collaborations.

From the earliest prototypes of ventricular assist devices to cutting-edge 3D bioprinted scaffolds, the development timeline reveals relentless innovation. Regulatory frameworks have adapted in parallel, establishing pathways for compassionate use, breakthrough device designations, and accelerated approvals. Simultaneously, payer systems are grappling with reimbursement paradigms for high-cost therapies that promise long-term savings in patient care. By appreciating this intricate backdrop, stakeholders can fully grasp the strategic significance of subsequent market developments and emerging opportunities.

Breakthroughs Redefining Artificial Organ Development

Breakthrough science and commercial imperatives are converging to rewrite the playbook for artificial organs. Advances in cell sourcing have unlocked new potential for stem cell therapies and primary cell applications, while scaffold designs now mimic native extracellular matrices with unprecedented fidelity. Microfluidics platforms are refining organ-on-chip models, accelerating preclinical validation and de-risking investment decisions. In parallel, mechanical systems are shedding decades-old limitations through miniaturization and enhanced energy efficiency, enabling truly wearable solutions.

Meanwhile, the advent of extrusion-based, inkjet-based, and laser-assisted 3D bioprinting has ushered in a new era of customization. Researchers can now pattern multiple cell types within a single construct, replicating complex tissue architecture. These transformative shifts are supported by collaborative ecosystems where academic institutions, device manufacturers, and contract research organizations share data and expertise. As these partnerships intensify, the pace of innovation quickens, heralding an era where the boundary between synthetic and biological repairs becomes increasingly blurred.

Navigating the Turbulence of New Tariff Regimes

New tariff schedules introduced in 2025 by the United States have reverberated across global supply chains, prompting manufacturers to reassess sourcing and production footprints. Components for dialysis machines, extracorporeal membrane oxygenation systems, and scaffold materials that once arrived duty-free are now subject to incremental levies. These cost pressures are particularly acute for hybrid functional units within bioartificial kidneys and bioreactor modules used in bioartificial liver systems.

In response, select companies have shifted manufacturing to regional hubs or pursued tariff exclusions through targeted petitions. Some device producers are optimizing designs to reduce reliance on high-tariff components, while others are negotiating supplier agreements that lock in favorable pricing. Investors and strategic planners are carefully monitoring further trade policy developments, recognizing that even modest duty adjustments can erode margins in a market where product complexity and R&D expenditures remain substantial. Ultimately, the ability to navigate these tariff challenges will distinguish resilient innovators from those encumbered by cost volatility.

Unveiling Market Dynamics Across Critical Segments

Insights into market dynamics crystallize when examining performance across organ type, product frameworks, enabling technologies, end users, and distribution pathways. Heart, kidney, liver, lung, and pancreas applications each present distinct clinical imperatives and regulatory considerations, compelling specialized research teams to address unique biological challenges. Bioartificial, mechanical, and tissue engineered categories reveal divergent investment patterns: hybrid functional units in bioartificial kidneys and hepatocyte-based liver systems demand interdisciplinary expertise, whereas dialysis machines and ventricular assist devices benefit from incremental enhancements to proven platforms.

Technological breakthroughs amplify these distinctions. Extrusion-based, inkjet-based, and laser-assisted bioprinting methodologies are redefining scaffold complexity, while decellularization techniques ensure faithful retention of native matrix cues. Microfluidics innovations streamline organ-on-chip validation, and wearable devices extend therapy beyond traditional clinical settings. Within care delivery environments, ambulatory clinics and day surgery centers contrast with the infrastructure of private and public hospitals, each shaping adoption cycles and reimbursement frameworks. Distribution channels further vary from direct sales alliances to digital platforms that cater to research institutes and specialty clinics. Together, these segmentation insights reveal a mosaic of opportunities and challenges that require nuanced strategic approaches.

Regional Dynamics Steering Market Growth and Adoption

A regional lens elucidates how demographics, regulatory climates, and healthcare infrastructures converge to shape adoption. In the Americas, extensive clinical trial networks and established reimbursement pathways underpin strong uptake of advanced mechanical systems and bioartificial prototypes. Conversely, Europe, Middle East & Africa presents a tapestry of heterogeneous regulations, with pockets of rapid innovation in bioprinting and scaffold design offset by reimbursement constraints in certain public health systems.

Asia-Pacific is emerging as a hotbed for cost-effective manufacturing and large-scale cell therapy research. Government-led initiatives in countries like Japan and South Korea are accelerating regenerative medicine approvals, while regional trade agreements facilitate cross-border collaboration in scaffold technology and microfluidics. These geographic distinctions demand adaptable market entry strategies, balancing global best practices with tailored regulatory and reimbursement plans that reflect local healthcare priorities.

Leading Innovators Shaping the Artificial Organ Arena

The competitive landscape is shaped by a blend of established medical device conglomerates and agile biotechnology innovators. Market leaders in mechanical support systems are leveraging decades of clinical data to enhance ventricular assist devices and extracorporeal membrane oxygenation platforms. Simultaneously, pioneers in bioartificial solutions are forging partnerships with academic centers to advance hepatocyte-based liver modules and hybrid functional units, while tissue engineered scaffolds receive fresh investment from venture capital focused on next-generation regenerative therapies.

These companies differentiate through strategic alliances, intellectual property portfolios, and integrated R&D pipelines that bridge biology and engineering. By aligning with contract development and manufacturing organizations, they accelerate scale-up processes for cell-based therapies and decellularized scaffolds. Moreover, collaborations with software developers are enhancing device connectivity, enabling remote monitoring and predictive maintenance. Observing these corporate strategies offers clear indicators of where the sector is heading and which capabilities will be most valued.

Strategic Imperatives to Capitalize on Emerging Opportunities

Industry leaders must prioritize cross-disciplinary collaboration, aligning engineers, biologists, regulatory experts, and reimbursement specialists from project inception. Establishing joint development agreements with academic institutions can fast-track preclinical validation, while dedicated tariff mitigation teams will safeguard profitability in the face of evolving trade policies. Optimizing supply chains by diversifying regional manufacturing hubs reduces exposure to import levies and geopolitical disruptions.

Furthermore, investing in digital platforms that integrate device connectivity, patient data analytics, and remote monitoring will create value for healthcare providers and payers alike. Tailored reimbursement strategies, co-created with health economics experts, will ensure that innovative therapies secure coverage and justify premium pricing. Finally, companies should cultivate transparent communication channels with regulatory bodies to leverage accelerated approval pathways and compassionate use programs. These strategic imperatives will position organizations to lead in the next wave of artificial organ advancements.

Robust Methodologies Underpinning Comprehensive Market Insights

This research is grounded in a rigorous hybrid methodology that combines primary stakeholder interviews, expert roundtables, and site visits with extensive secondary research across peer-reviewed journals, industry reports, and global regulatory databases. Primary insights were sourced through direct conversations with surgeons, bioengineers, payers, and procurement officers to validate key trends and challenges. Secondary data collection encompassed clinical trial registries, patent filings, and tariff documentation, ensuring comprehensive coverage of market drivers and restraints.

Quantitative analysis employed cross-verification techniques, triangulating data points from proprietary sales databases with public financial disclosures. Qualitative findings were subjected to peer review by subject-matter experts to guarantee accuracy and relevance. This robust approach ensures that conclusions reflect the most current evidence and that actionable recommendations are both practical and strategic.

Converging Towards a Sustainable Future in Artificial Organs

The evolution of artificial organs stands at an inflection point where scientific breakthroughs, regulatory adaptations, and global economic forces converge to redefine patient care. By synthesizing insights across technological, clinical, and commercial dimensions, stakeholders can craft strategies that drive innovation while managing cost and complexity. The interplay between tariff policies, regional market characteristics, and segmentation dynamics highlights the importance of agility and foresight.

Ultimately, the organizations that excel will be those that embrace interdisciplinary collaboration, harness digital ecosystems, and align product development with nuanced reimbursement frameworks. As the gap between supply and demand for life-saving organ solutions widens, the imperative to deliver safe, effective, and accessible therapies has never been greater. This executive summary offers a roadmap for navigating the challenges ahead and capitalizing on the transformative potential of artificial organs.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Organ Type
    • Heart
    • Kidney
    • Liver
    • Lung
    • Pancreas
  • Product Type
    • Bioartificial
      • Bioartificial Kidney
        • Filtration-Based Systems
        • Hybrid Functional Units
      • Bioartificial Liver
        • Hepatocyte-Based Systems
        • Scaffold-Based Units
    • Mechanical
      • Dialysis Machine
        • Hemodialysis
        • Peritoneal Dialysis
      • Extracorporeal Membrane Oxygenation
        • VA-ECMO
        • VV-ECMO
      • Ventricular Assist Device
        • Left Ventricular Assist Device
        • Right Ventricular Assist Device
    • Tissue Engineered
      • Cell-Based Therapies
        • Primary Cell Therapies
        • Stem Cell Therapies
      • Scaffold-Based Constructs
        • Decellularized Scaffolds
        • Functionalized Scaffolds
  • Technology
    • 3D Bioprinting
      • Extrusion-Based
      • Inkjet-Based
      • Laser-Assisted
    • Decellularization
    • Microfluidics
    • Scaffold Technology
    • Wearable Devices
  • End User
    • Ambulatory Care Centers
      • Clinics
      • Day Surgery Centers
    • Hospitals
      • Private Hospitals
      • Public Hospitals
    • Research Institutes
    • Specialty Clinics
  • Distribution Channel
    • Direct Sales
    • Distributors
    • Hospital Procurement
    • Online Platforms
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Fresenius Medical Care AG & Co. KGaA
  • Baxter International Inc.
  • Medtronic plc
  • Abbott Laboratories
  • Getinge AB
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • Abiomed, Inc.
  • Carmat SA

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Artificial Organs Market, by Organ Type
8.1. Introduction
8.2. Heart
8.3. Kidney
8.4. Liver
8.5. Lung
8.6. Pancreas
9. Artificial Organs Market, by Product Type
9.1. Introduction
9.2. Bioartificial
9.2.1. Bioartificial Kidney
9.2.1.1. Filtration-Based Systems
9.2.1.2. Hybrid Functional Units
9.2.2. Bioartificial Liver
9.2.2.1. Hepatocyte-Based Systems
9.2.2.2. Scaffold-Based Units
9.3. Mechanical
9.3.1. Dialysis Machine
9.3.1.1. Hemodialysis
9.3.1.2. Peritoneal Dialysis
9.3.2. Extracorporeal Membrane Oxygenation
9.3.2.1. VA-ECMO
9.3.2.2. VV-ECMO
9.3.3. Ventricular Assist Device
9.3.3.1. Left Ventricular Assist Device
9.3.3.2. Right Ventricular Assist Device
9.4. Tissue Engineered
9.4.1. Cell-Based Therapies
9.4.1.1. Primary Cell Therapies
9.4.1.2. Stem Cell Therapies
9.4.2. Scaffold-Based Constructs
9.4.2.1. Decellularized Scaffolds
9.4.2.2. Functionalized Scaffolds
10. Artificial Organs Market, by Technology
10.1. Introduction
10.2. 3D Bioprinting
10.2.1. Extrusion-Based
10.2.2. Inkjet-Based
10.2.3. Laser-Assisted
10.3. Decellularization
10.4. Microfluidics
10.5. Scaffold Technology
10.6. Wearable Devices
11. Artificial Organs Market, by End User
11.1. Introduction
11.2. Ambulatory Care Centers
11.2.1. Clinics
11.2.2. Day Surgery Centers
11.3. Hospitals
11.3.1. Private Hospitals
11.3.2. Public Hospitals
11.4. Research Institutes
11.5. Specialty Clinics
12. Artificial Organs Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Hospital Procurement
12.5. Online Platforms
13. Americas Artificial Organs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Artificial Organs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Artificial Organs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Fresenius Medical Care AG & Co. KGaA
16.3.2. Baxter International Inc.
16.3.3. Medtronic plc
16.3.4. Abbott Laboratories
16.3.5. Getinge AB
16.3.6. B. Braun Melsungen AG
16.3.7. Terumo Corporation
16.3.8. Nipro Corporation
16.3.9. Abiomed, Inc.
16.3.10. Carmat SA
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ARTIFICIAL ORGANS MARKET MULTI-CURRENCY
FIGURE 2. ARTIFICIAL ORGANS MARKET MULTI-LANGUAGE
FIGURE 3. ARTIFICIAL ORGANS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ARTIFICIAL ORGANS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ARTIFICIAL ORGANS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ARTIFICIAL ORGANS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY LUNG, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY FILTRATION-BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY HYBRID FUNCTIONAL UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY HEPATOCYTE-BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED UNITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY HEMODIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY PERITONEAL DIALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY VA-ECMO, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY VV-ECMO, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY RIGHT VENTRICULAR ASSIST DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY PRIMARY CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY STEM CELL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY DECELLULARIZED SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY FUNCTIONALIZED SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY EXTRUSION-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY INKJET-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY LASER-ASSISTED, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY DECELLULARIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY DAY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITAL PROCUREMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL ARTIFICIAL ORGANS MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES ARTIFICIAL ORGANS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 111. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 112. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 113. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 114. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 115. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 116. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 117. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 118. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 119. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 120. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 121. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 122. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 123. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 124. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 125. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 127. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 128. CANADA ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 130. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 132. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 133. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 134. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 135. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 136. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 137. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 138. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 139. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 140. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 141. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 142. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 143. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 145. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 146. MEXICO ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL ORGANS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 221. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 223. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 224. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 225. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 226. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 227. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 228. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 229. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 230. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 231. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 232. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 234. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 236. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 237. GERMANY ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 239. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 240. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 241. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 242. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 243. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 244. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 245. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 246. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 247. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 248. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 249. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 250. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 252. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 254. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. FRANCE ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 275. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 276. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 277. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 278. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 279. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 280. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 281. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 282. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 283. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 284. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 285. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 286. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 287. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 288. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 289. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 290. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 291. ITALY ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 293. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 294. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 295. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 296. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 297. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 298. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 299. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 300. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 301. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 302. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 303. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 304. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 306. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 307. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 308. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 309. SPAIN ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL LIVER, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY MECHANICAL, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY DIALYSIS MACHINE, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY EXTRACORPOREAL MEMBRANE OXYGENATION, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY VENTRICULAR ASSIST DEVICE, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY TISSUE ENGINEERED, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY CELL-BASED THERAPIES, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY SCAFFOLD-BASED CONSTRUCTS, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY 3D BIOPRINTING, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY AMBULATORY CARE CENTERS, 2018-2030 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES ARTIFICIAL ORGANS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. SAUDI ARABIA ARTIFICIAL ORGANS MARKET SIZE, BY ORGAN TYPE, 2018-2030 (USD MILLION)
TABLE 329. SAUDI ARABIA ARTIFICIAL ORGANS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 330. SAUDI ARABIA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL, 2018-2030 (USD MILLION)
TABLE 331. SAUDI ARABIA ARTIFICIAL ORGANS MARKET SIZE, BY BIOARTIFICIAL KIDNEY, 2018-2030 (USD MILLION)
TABLE 332. SAUDI

Companies Mentioned

The companies profiled in this Artificial Organs market report include:
  • Fresenius Medical Care AG & Co. KGaA
  • Baxter International Inc.
  • Medtronic plc
  • Abbott Laboratories
  • Getinge AB
  • B. Braun Melsungen AG
  • Terumo Corporation
  • Nipro Corporation
  • Abiomed, Inc.
  • Carmat SA

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 26.45 Billion
Forecasted Market Value ( USD ) by 2030 $ 39.56 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Artificial Organ Bank Market by Organ Type, Application, End User, Technology, Material Type - Global Forecast to 2030 - Product Image

Artificial Organ Bank Market by Organ Type, Application, End User, Technology, Material Type - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Artificial Organ & Bionics Market by Product, Application, Technology, End User - Global Forecast to 2030 - Product Image

Artificial Organ & Bionics Market by Product, Application, Technology, End User - Global Forecast to 2030

  • Report
  • 192 Pages
  • Global
From
Wearable Artificial Organs Market Size, Share & Trends Analysis Report By Artificial Organ (Kidney, Pancreas, Cochlear Implant, Exoskeleton, Bionic Limbs, Brain Bionics, Vision Bionics), By Technology, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Wearable Artificial Organs Market Size, Share & Trends Analysis Report By Artificial Organ (Kidney, Pancreas, Cochlear Implant, Exoskeleton, Bionic Limbs, Brain Bionics, Vision Bionics), By Technology, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 110 Pages
  • Global
From
Artificial Vital Organs And Medical Bionics Market Size, Share & Trends Analysis Report By Artificial Organs (Heart, Kidney, Liver), By Bionics (Ear Bionics, Vision Bionics, Exoskeletons), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Artificial Vital Organs And Medical Bionics Market Size, Share & Trends Analysis Report By Artificial Organs (Heart, Kidney, Liver), By Bionics (Ear Bionics, Vision Bionics, Exoskeletons), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Artificial Organs and Bionics - Global Strategic Business Report - Product Image

Artificial Organs and Bionics - Global Strategic Business Report

  • Report
  • 129 Pages
  • Global
From

About the Artificial Organ Market

The Artificial Organ market is a subset of the Biomaterials industry, which focuses on the development of materials for use in medical applications. Artificial organs are designed to replace or supplement the function of a damaged or missing organ, and can be made from a variety of materials, including polymers, metals, and ceramics. These materials are chosen for their biocompatibility, durability, and ability to interact with the body's natural systems. The Artificial Organ market is driven by advances in medical technology, as well as the increasing prevalence of chronic diseases and organ failure. The market is expected to grow in the coming years, as more people seek out treatments for their conditions. Companies in the Artificial Organ market include Abiomed, SynCardia Systems, and WorldHeart Corporation. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.